General Internal Medicine

Medicine & Life Sciences

1. Vaccines 100%
2. Vaccination 88%
3. Breast Neoplasms 74%
4. Physicians 73%
5. Measles 67%
6. Breast 58%
7. Systematic Reviews 55%
8. Measles Vaccine 54%
9. Therapeutics 53%
10. Human Influenza 52%
11. Meta-Analysis 47%
12. Fibromyalgia 45%
13. Internal Medicine 44%
14. Tobacco Use Disorder 42%
15. Rubella 40%
16. Genes 40%
17. Randomized Controlled Trials 39%
18. Measles virus 38%
19. Humoral Immunity 38%
20. Psychological Burnout 38%
21. Delivery of Health Care 37%
22. Population 35%
23. Single Nucleotide Polymorphism 35%
24. Smoking Cessation 34%
25. Influenza Vaccines 34%
26. Molecular Imaging 32%
27. HLA Antigens 32%
28. Menopause 32%
29. Smallpox Vaccine 31%
30. Induced Pluripotent Stem Cells 31%
31. Enteral Nutrition 31%
32. Neoplasms 31%
33. Health 30%
34. Antibodies 29%
35. Medicine 29%
36. Immunization 29%
37. Home Parenteral Nutrition 28%
38. Complementary Therapies 28%
39. Immunity 28%
40. Confidence Intervals 27%
41. Safety 27%
42. Cytokines 27%
43. Cancer Survivors 27%
44. Quality of Life 27%
45. Adipocytes 27%
46. Fats 26%
47. Obesity 26%
48. Cellular Immunity 25%
49. Education 25%
50. Pain 25%
51. Measles-Mumps-Rubella Vaccine 25%
52. Mortality 25%
53. Smallpox 25%
54. Alleles 24%
55. Varenicline 24%
56. Placebos 24%
57. Rubella virus 24%
58. Estrogens 24%
59. Stem Cells 23%
60. Smokers 23%
61. Rubella Vaccine 23%
62. Odds Ratio 23%
63. Adipose Tissue 23%
64. Acupuncture 22%
65. Breast Density 22%
66. Hormones 22%
67. Smoking 22%
68. Massage 21%
69. Guidelines 21%
70. Clinical Trials 21%
71. Palliative Care 21%
72. Kidney 20%
73. Electronic Health Records 20%
74. Clinical Decision Support Systems 20%
75. Elderly 20%
76. Antibody Formation 20%
77. Fatigue 20%
78. Mumps 19%
79. Systematized Nomenclature of Medicine 19%
80. Hot Flashes 19%
81. Vaccinology 19%
82. Bupropion 18%
83. Ovariectomy 18%
84. Integrative Medicine 18%
85. Cohort Studies 17%
86. Pandemics 17%
87. Patient Care 17%
88. Anxiety 17%
89. Tobacco 17%
90. Infections 16%
91. Electroconvulsive Therapy 16%
92. Costs and Cost Analysis 16%
93. Neutralizing Antibodies 16%
94. Transplants 16%
95. Technology 16%
96. Biopsy 16%
97. Communication 15%
98. Haplotypes 15%
99. Heart Failure 15%